Drug intelligence / Profile preview

Ferric Z

Development stage: Unknown
Lead developer: El Dorado Bio Tech
Modality: Small Molecules
Administration: Oral

Overview

Ferric Z is an over-the-counter nutraceutical supplement developed by El Dorado Bio Tech, containing a combination of ferrous ascorbate, folic acid, and zinc. It is primarily indicated for the prevention and treatment of iron deficiency anemia and associated nutritional deficiencies. Ferrous ascorbate provides a highly bioavailable form of iron for hemoglobin synthesis, folic acid supports DNA production and red blood cell maturation, and zinc acts as a cofactor for numerous enzymatic reactions and immune system maintenance.

Brand names: Ferric Z
Other names: ferrous ascorbate/folic acid/zinc tablets

Beyond the preview

Go deeper on Ferric Z.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferric Z.

Explore the full profile